BioCentury
ARTICLE | Company News

Bharat Biotech infectious news

January 2, 2012 8:00 AM UTC

The World Health Organization (WHO) suspended the supply of Bharat's Revac B+ hepatitis B vaccine after the agency found GMP deficiencies at the company's Hyderabad plant during a September 2011 site audit. WHO said it also stopped the prequalification process for all products produced at the plant. WHO, which did not recommend a recall of the vaccines, said it will conduct a second audit within three months of the Nov. 28, 2011, notification to Bharat of the suspension. ...